Nativis Enters into Exclusive Licensing Agreement for Glioblastoma Multiforme in Japan

April 4, 2017 Nativis, a clinical-stage life science bio-electronic company developing non-invasive, safe and highly effective treatments for cancers and other serious diseases, today announced that the company has entered into an exclusive licensing agreement for the development...

InDevR Collaborates with I&L Biosystems to Market Products in Western Europe: Includes Sales & Support for CypherOne & Soon to Launch VaxArray

The company manufactures and sells Cypher One™, an automated hemagglutination analyzer used by biopharmaceutical vaccine manufacturers and veterinary diagnostic labs.